Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature.
K P Townsend; D Obregon; A Quadros; N Patel; Ch Volmar; D Paris; M Mullan (Profiled Author: Mullan, Michael)
Department of Psychiatry, Roskamp Institute, University of South Florida, 3515 Fletcher Avenue, Tampa, FL 33613, USA.
Annals of the New York Academy of Sciences 2002;977():65-76.
Abeta peptides are thought to be critical molecules in the pathophysiology of Alzheimer's disease (AD) and are the major protein constituents of senile plaques. In most AD cases, Abeta peptides also form some deposits in the cerebrovasculature, leading to cerebral amyloid angiopathy and hemorrhagic stroke. Regional cerebral hypoperfusion is one of the earlier clinical manifestations in both the sporadic and familial forms of AD. In addition, a variety of vascular risk factors of different etiologies (for instance, diabetes, hypertension, high cholesterol level, atherosclerosis, and smoking) constitute risk factors for AD as well, suggesting that functional vascular abnormalities may contribute to AD pathology. We studied the effect of Abeta on constrictor responses elicited by endothelin-1 in isolated human cerebral arteries collected following rapid autopsies. We report that freshly solubilized Abeta potentiates endothelin-1-induced vasoconstriction in isolated human middle cerebral and basilar arteries. The vasoconstriction elicited by Abeta in these large human cerebral arteries appears to be completely antagonized by NS-398, a selective cyclooxygenase-2 inhibitor, or by SB202190, a specific p38 mitogen-activated protein kinase inhibitor, suggesting that Abeta vasoactivity is mediated via the stimulation of a proinflammatory pathway. In addition, a similar proinflammatory response appears to be mediated by Abeta in isolated human brain microvessels, resulting in an increased production of prostaglandin E(2) and F(2alpha). Using a scanner laser Doppler imager, we show a progressive decline with aging in cortical perfusion level in transgenic APPsw mice (line 2576) compared with age-matched control littermates. The relation between the acute proinflammatory and vasoactive properties of Abeta and the chronic progressive hypoperfusion seen in AD (and transgenic models thereof) is yet to be elucidated.
1 Originating Grant
-
1.
Mullan, Michael J
1 April 2001 - 30 April 2010
NATIONAL INSTITUTE ON AGING
Total Funding: $ 2,322,764
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
MAYEUX, RICHARD
Epidemiology of Biomarkers of Risk and Progression in LOAD
1 May 2010 - 30 April 2015
NATIONAL INSTITUTE ON AGING
Total Funding: $ 5,932,714
-
2.
SELKOE, DENNIS J
Protein-Protein Interactions in the Biology of Beta-APP
1 January 1995 - 31 August 2013
NATIONAL INSTITUTE ON AGING
Total Funding: $ 5,885,071
-
3.
RAPOPORT, STANLEY I
Brain Imaging In Human Aging, Alzheimer Disease And Other Disorders
NATIONAL INSTITUTE ON AGING
Total Funding: $ 561,942
Related Publications
-
1.
2003Daniel Paris; James Humphrey; Amita Quadros; Nikunj Patel; Robert Crescentini; Fiona Crawford; Michael Mullan
Neurological research 2003;25(6):642-51. -
2.
2004Daniel Paris; Amita Quadros; James Humphrey; Nikunj Patel; Robert Crescentini; Fiona Crawford; Michael Mullan
Brain research 2004;999(1):53-61. -
3.
1998F Crawford; Z Suo; C Fang; M Mullan
Characteristics of the in vitro vasoactivity of beta-amyloid peptides.
Experimental neurology 1998;150(1):159-68.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
439









-
190









-
411









-
610









-
779









-
540










